IRIS
LAZZERINI, PIETRO ENEA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.227
EU - Europa 10.464
AS - Asia 5.825
SA - Sud America 1.043
Continente sconosciuto - Info sul continente non disponibili 481
AF - Africa 304
OC - Oceania 20
AN - Antartide 1
Totale 32.365
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.953
IT - Italia 2.079
CN - Cina 1.992
GB - Regno Unito 1.918
RU - Federazione Russa 1.915
SG - Singapore 1.793
IE - Irlanda 1.178
BR - Brasile 857
DE - Germania 773
SE - Svezia 740
VN - Vietnam 552
UA - Ucraina 549
FR - Francia 521
HK - Hong Kong 458
FI - Finlandia 388
KR - Corea 312
IN - India 198
CA - Canada 143
BD - Bangladesh 115
ZA - Sudafrica 114
NL - Olanda 77
TR - Turchia 71
ES - Italia 68
AR - Argentina 59
IQ - Iraq 54
MX - Messico 54
CI - Costa d'Avorio 49
PL - Polonia 44
JP - Giappone 41
NG - Nigeria 41
BE - Belgio 38
CO - Colombia 33
EC - Ecuador 33
KE - Kenya 30
CZ - Repubblica Ceca 29
AT - Austria 27
PK - Pakistan 26
ID - Indonesia 25
TH - Thailandia 25
VE - Venezuela 24
GR - Grecia 18
AU - Australia 16
EE - Estonia 15
PH - Filippine 15
EG - Egitto 14
JM - Giamaica 14
TN - Tunisia 14
UZ - Uzbekistan 14
IL - Israele 13
MA - Marocco 13
SA - Arabia Saudita 13
LT - Lituania 12
AE - Emirati Arabi Uniti 11
KZ - Kazakistan 11
JO - Giordania 10
RO - Romania 10
AZ - Azerbaigian 9
CH - Svizzera 9
CL - Cile 9
CR - Costa Rica 9
MY - Malesia 9
TT - Trinidad e Tobago 9
DZ - Algeria 8
IR - Iran 8
NP - Nepal 8
PY - Paraguay 8
ET - Etiopia 7
EU - Europa 7
HN - Honduras 7
KG - Kirghizistan 7
SV - El Salvador 7
BA - Bosnia-Erzegovina 6
BO - Bolivia 6
DO - Repubblica Dominicana 6
HU - Ungheria 6
OM - Oman 6
PE - Perù 6
AL - Albania 5
BG - Bulgaria 5
HR - Croazia 5
RS - Serbia 5
CY - Cipro 4
GT - Guatemala 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
PA - Panama 4
PR - Porto Rico 4
SC - Seychelles 4
SK - Slovacchia (Repubblica Slovacca) 4
SY - Repubblica araba siriana 4
BY - Bielorussia 3
DK - Danimarca 3
GY - Guiana 3
LB - Libano 3
LC - Santa Lucia 3
SN - Senegal 3
AG - Antigua e Barbuda 2
BB - Barbados 2
BH - Bahrain 2
LA - Repubblica Popolare Democratica del Laos 2
Totale 31.848
Salva come PNG Salva come JPEG
Città #
Southend 1.606
Dallas 1.548
Ashburn 1.321
Fairfield 1.169
Dublin 1.143
Singapore 992
San Jose 678
Chandler 599
Santa Clara 571
Milan 548
Woodbridge 544
Moscow 537
Beijing 471
Houston 470
Hong Kong 439
Hefei 436
Seattle 434
Jacksonville 433
Wilmington 424
Cambridge 397
Council Bluffs 368
Siena 365
Menlo Park 308
Seoul 305
Ann Arbor 291
Helsinki 237
The Dalles 210
Los Angeles 209
Princeton 209
New York 205
Rome 166
Nanjing 155
Ho Chi Minh City 148
Lauterbourg 147
Columbus 131
Dong Ket 125
Florence 121
Munich 116
Boardman 114
Hanoi 113
Johannesburg 101
Buffalo 96
Dearborn 94
San Diego 81
Vimercate 78
São Paulo 75
San Mateo 65
Nanchang 60
Bengaluru 57
Chicago 57
Orem 55
Brooklyn 53
Phoenix 51
Shanghai 51
Abidjan 49
Turku 47
Toronto 46
Shenyang 44
London 43
Málaga 40
Frankfurt am Main 39
San Francisco 39
Abuja 38
Brussels 36
Redondo Beach 36
Turin 36
Tokyo 34
Warsaw 34
Atlanta 33
Changsha 33
Lappeenranta 33
Denver 32
Figino 32
Amsterdam 31
Montreal 31
Nuremberg 29
Poggiomarino 29
Boston 28
Hebei 27
Lancaster 27
Guangzhou 26
Izmir 26
Mumbai 26
Tianjin 26
Rio de Janeiro 25
Düsseldorf 24
Jinan 24
Washington 24
Kunming 23
Belo Horizonte 21
Chennai 21
Jiaxing 21
Norwalk 21
Baghdad 19
Bologna 19
Brasília 19
Da Nang 19
Manchester 19
Naples 19
Ankara 18
Totale 21.143
Salva come PNG Salva come JPEG
Nome #
Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes 437
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 434
Antiarrhythmic potential of anticytokine therapy in rheumatoid arthritis: tocilizumab reduces corrected QT interval by controlling systemic inflammation 421
Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system 420
Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts 405
Proton pump inhibitors directly block hERG-potassium channel and independently increase the risk of QTc prolongation in a large cohort of US Veterans 395
Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6–Mediated Changes in Connexin Expression 388
Antirheumatic agents in covid-19: is IL-6 the right target? 375
Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis 375
Proton pump inhibitors and serum magnesium levels in patients with Torsades de Pointes 355
Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis 347
Anti-Ro/SSA Antibodies Blocking Calcium Channels as a Potentially Reversible Cause of Atrioventricular Block in Adults 337
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity 331
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 329
Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis 327
Spotlight on sirukumab for the treatment of rheumatoid arthritis: The evidence to date 315
P wave dispersion in cryptogenic stroke: A risk factor for cardioembolism? 312
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis 311
Adenosine receptors expression in cardiac fibroblasts of patients with left ventricular dysfunction due to valvular disease 310
Acute effects of glibenclamide on reactive hyperaemia in the lower limbs in humans 303
Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications 303
Induction of autoimmune response to the extracellular loop of the HERG channel pore induces QTc prolongation in guinea-pigs 301
Advanced Atrioventricular Block in Athletes: Prevalence and Role of Anti-Ro/Sjögren Syndrome-Related Antigen A Antibodies 297
Non-HCV-related cryoglobulinemic vasculitis and parvovirus-B19 infection 295
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 286
Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation 286
Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes 286
Correlation between cardiac oxidative stress and myocardial pathology due to acute and chronic norepinephrine administration in rats 275
Autoimmune and inflammatory K+ channelopathies in cardiac arrhythmias: Clinical evidence and molecular mechanisms 270
Torsades de Pointes in patients with polymyalgia rheumatica 265
Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, cross-over study in patients with chronic arthritis 263
Alteration in the redox state of plasma in heart transplanted patients with moderate hyperhomocisteinemia 258
Simvastatin inhibits T cell activation by selectively impairing the function of RAS superfamily GTPases 256
Levels of circulating CXCR4-positive cells are decreased and negatively correlated with risk factors in cardiac transplant recipients 253
Human rheumatoid synoviocytes express functional P2X7 receptors 251
Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA positive connective tissue diseases 250
The effects of age and hyperhomocysteinemia on the redox forms of plasma thiols 250
Cardiac arrest risk during acute infections: systemic inflammation directly prolongs QTc interval via cytokine-mediated effects on potassium channel expression 250
Assessing QT interval in patients with autoimmune chronic inflammatory diseases: perils and pitfalls 250
Cyclosporin and tacrolimus increase plasma levels of adenosine in kidney transplanted patients 249
Anti-Ro/SSA antibodies and cardiac arrhythmias in the adult: facts and hypotheses 248
Editorial: Insights in General Cardiovascular Medicine: 2021 246
Isolated atrioventricular block of unknown origin in the adult and autoimmunity: Diagnostic and therapeutic considerations exemplified by 3 anti-Ro/SSA-associated cases 246
The role of P2X7 receptors in tissue fibrosis: a brief review 245
Neutrophil extracellular traps release in gout and pseudogout depends on the number of crystals regardless of leukocyte count 245
Arrhythmogenic effects of anti-Ro/SSA antibodies on theadult heart: more than expected? 243
Statins and the joint: multiple targets for a global protection? 242
SEX HORMONES IN LONG QT SYNDROME AND TORSADES DE POINTES (TDP) 240
Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad 239
Cardiac dysautonomia in patients with superior vena cava syndrome due to compression by lung cancer. 237
Connective tissue diseases and cardiac rhythm disorders: an overview 236
Le indicazioni al trattamento con immunoglobuline endovena nelle malattie reumatiche. [Indications for intra-venous immunoglobulin treatment in rheumatic diseases] 235
Increased arterial stiffness is an independent risk factor for hemorrhagic transformation in ischemic stroke undergoing thrombolysis 235
Atrial cardiopathy and sympatho-vagal imbalance in cryptogenic stroke: Pathogenic mechanisms and effects on electrocardiographic markers 230
Pravastatin treatment-associated reduction in plasma homocysteine in heart-transplanted patients 228
Early and delayed increase in plasma homocysteine levels in heart transplanted patients 223
T lymphocytes as targets of statins: molecular mechanisms and therapeutic perspectives 223
Psychosine-induced apoptosis and cytokine activation in immune peripheral cells of Krabbe patients. 217
Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells 216
The "Invulnerability" of the Adult Conduction System to Anti-Ro/SSA Antibodies? A Matter of Calcium Channel Expression on the Cardiomyocyte 215
Transient hypogonadism is associated with heart rate-corrected QT prolongation and torsades de pointes risk during active systemic inflammation in men 214
Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias 213
Urinary tract infections caused by Gram-negative bacteria in elderly hospitalized patients: epidemiology, clinical features and outcomes in the era of antimicrobial resistance 212
Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation 212
Isolated atrioventricular block of unknown origin in adults and anti-Ro/SSA antibodies: Clinical evidence, putative mechanisms, and therapeutic implications 210
Elevated Interleukin-6 Levels Are Associated With an Increased Risk of QTc Interval Prolongation in a Large Cohort of US Veterans 210
Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation 209
How to Identify Patients at Risk of Silent Atrial Fibrillation after Cryptogenic Stroke: Potential Role of P Wave Dispersion 208
Emerging arrhythmic risk of autoimmune and inflammatory cardiac channelopathies 207
Inflammatory cytokines, life-threatening arrhythmias and premature mortality in chronic inflammatory arthritis: Time to focus on 203
Interleukin-6 elevation Is a key pathogenic factor underlying COVID-19-associated heart rate-corrected QT interval prolongation 201
Pathogenesis of the novel autoimmune-associated long-QT syndrome 201
Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome, and Torsades de Pointes Risk 200
Previous use of statins and atrial electrical remodeling in patients with cryptogenic stroke 198
Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies 197
Simvastatin reduces MMP-3 level in interleukin 1b-stimulated human chondrocyte culture 191
Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts 190
Photopheresis immunomodulation after heart transplantation 187
Clinically-relevant cyclosporin and rapamycin concentrations enhance regulatory T cell function to a similar extent but with different mechanisms: An in-vitro study in healthy humans. 186
Reduction in plasma homocysteine level in patients with rheumatoid arthritis given pulsed glucocorticoid treatment 186
P wave dispersion and silent atrial fibrillation in cryptogenic stroke: The pathogenic role of inflammation 186
Long QT Syndrome: An Emerging Role for Inflammation and Immunity 184
Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A oral echocardiographic study 183
Autoimmune Calcium Channelopathies and Cardiac Electrical Abnormalities 183
Blunted increase in plasma adenosine levels following dipyridamole stress test in dilated cardiomyopathy patients 182
Inhibitory effect of synthetic cannabinoids on cytokine production in rheumatoid fibroblast-like synoviocytes 180
Homocysteine and Raynaud’s phenomenon: a review 180
Comment on “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty?” 179
Comment on: Letter to the Editor from Clockaerts and Bierma-Zeinstra 178
The Impact of Sex and Arterial Stiffness Interactions on the Outcome after an Acute Ischemic Stroke: A Retrospective Cohort Study 174
Potassium Channel Block and Novel Autoimmune-Associated Long QT Syndrome 173
Homocysteine and P wave dispersion in patients with heart transplantation 169
Statins as a new therapeutic perspective in myocarditis and postmyocarditis dilated cardiomyopathy 167
Risk of qtc interval prolongation associated with circulating anti-ro/ssa antibodies among us veterans: an observational cohort study 165
Increased interleukin-6 levels are associated with atrioventricular conduction delay in severe COVID-19 patients 164
Simvastatin inhibits cytokine production and nuclear factor-kB activation in interleukin 1beta-stimulated synoviocytes from rheumatoid arthritis patients 164
Corrected QT interval in anti-SSA-positive adults with connective tissue disease: Comment on the article by Lazzerini et al. [6] (multiple letters) 164
Editorial: Insights in general cardiovascular medicine: 2022 163
Hyperhomocysteinemia: a cardiovascular risk factor in autoimmunediseases? 161
Anti-Ro/SSA Antibodies and the Autoimmune Long-QT Syndrome 157
Totale 24.801
Salva come PNG Salva come JPEG
Categoria #
all - tutte 101.852
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.852
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.448 0 0 0 146 130 55 91 146 142 167 196 375
2022/20232.267 144 244 310 318 179 435 78 160 228 65 60 46
2023/20241.995 69 39 149 100 94 534 607 61 33 46 78 185
2024/20254.348 89 201 365 256 491 276 197 273 347 214 442 1.197
2025/202610.899 860 1.579 1.046 1.218 1.821 464 1.210 300 373 587 433 1.008
2026/20272.337 523 566 813 435 0 0 0 0 0 0 0 0
Totale 32.365